Tosoh Tuesday - Scalable Purification Platform for Biosimilar Antibody Production

Tu, 17.11.2026 15:00 CET
Discover two-step purification of biosimilar mAbs using TOYOPEARL Super A (Protein A) and Sulfate-650F (CEX), plus HIC/AEX strategies for efficient impurity removal.
Tosoh Bioscience: Tosoh Tuesday - Scalable Purification Platform for Biosimilar Antibody Production
Tosoh Bioscience: Tosoh Tuesday - Scalable Purification Platform for Biosimilar Antibody Production

On November 17, Abbie Breton, Applications Development Manager, will host the next edition of Tosoh Tuesday, a webinar series held by Chromatography Experts. Yuliya McAnany, Applications Scientist - Process Resins at Tosoh Bioscience, will present a two-step purification of biosimilar monoclonal antibodies (mAbs).

As the patents for critical biologics expire, the demand to bring biosimilars to market offers a unique opportunity to deliver these treatments to patients at a more accessible price. Yuliya will demonstrate how TOYOPEARL Super A (Protein A affinity) and TOYOPEARL Sulfate-650F (salt-tolerant CEX) resins deliver exceptional performance while improving process economics. She will also share insights into TOYOPEARL Phenyl FT-750F (low-salt HIC) and TOYOPEARL NH2-750F (salt-tolerant AEX), two resins designed for flow-through mode which offer exceptional impurity clearance of complex molecules, while maintaining high throughput for reducing $/g.

After the webinar, ask your questions during the live Q and A session. 

Presenter: Abbie Breton (Applications Development Manager, Tosoh Bioscience)

Presenter: Yuliya McAnany (Applications Scientist - Process Resins, Tosoh Bioscience)

Tosoh Bioscience
LinkedIn Logo